.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2014 for a tremendous $43 b...
.On the heels of a stage 3 win that fell short to wow entrepreneurs, Ironwood Pharmaceuticals is bac...
.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizin...
.Welcome to this week's Chutes & Ladders, our roundup of considerable management hirings, shootin...
.Commemorating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey F...
.AbbVie has actually come back to the resource of its antipsychotic powerhouse Vraylar trying to fin...
.GenSight Biologics is weeks off of running out of loan. Once again. The biotech simply has sufficie...
.Monopar Therapeutics is bouncing back a medication from the scrap heap of AstraZeneca's unusual dis...
.With new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of analysts esti...
.After forming a genetics treatment alliance with Dyno Rehabs in 2020, Roche is back for even more.I...